These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 17728238)

  • 21. Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identical.
    He Y; Weinberg MS; Hirsch M; Johnson MC; Tisch R; Samulski RJ; Li C
    Hum Gene Ther; 2013 May; 24(5):545-53. PubMed ID: 23534873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors.
    Chen M; Maeng K; Nawab A; Francois RA; Bray JK; Reinhard MK; Boye SL; Hauswirth WW; Kaye FJ; Aslanidi G; Srivastava A; Zajac-Kaye M
    Hum Gene Ther Methods; 2017 Feb; 28(1):49-59. PubMed ID: 28125909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and Biophysical Analysis of Adeno-Associated Virus Serotype 2 Capsid Assembly Variants.
    Bennett A; Gargas J; Kansol A; Lewis J; Hsi J; Hull J; Mietzsch M; Tartaglia L; Muzyczka N; Bhattacharya N; Chipman P; Agbandje-McKenna M; McKenna R
    J Virol; 2023 Jul; 97(7):e0177222. PubMed ID: 37310260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.
    Boye SL; Bennett A; Scalabrino ML; McCullough KT; Van Vliet K; Choudhury S; Ruan Q; Peterson J; Agbandje-McKenna M; Boye SE
    J Virol; 2016 Apr; 90(8):4215-4231. PubMed ID: 26865709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural characterization of the dual glycan binding adeno-associated virus serotype 6.
    Ng R; Govindasamy L; Gurda BL; McKenna R; Kozyreva OG; Samulski RJ; Parent KN; Baker TS; Agbandje-McKenna M
    J Virol; 2010 Dec; 84(24):12945-57. PubMed ID: 20861247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative structural, biophysical, and receptor binding study of true type and wild type AAV2.
    Bennett A; Hull J; Jolinon N; Tordo J; Moss K; Binns E; Mietzsch M; Hagemann C; Linden RM; Serio A; Chipman P; Sousa D; Broecker F; Seeberger P; Henckaerts E; McKenna R; Agbandje-McKenna M
    J Struct Biol; 2021 Dec; 213(4):107795. PubMed ID: 34509611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
    Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
    J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface loop dynamics in adeno-associated virus capsid assembly.
    DiPrimio N; Asokan A; Govindasamy L; Agbandje-McKenna M; Samulski RJ
    J Virol; 2008 Jun; 82(11):5178-89. PubMed ID: 18367523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.
    Xie Q; Bu W; Bhatia S; Hare J; Somasundaram T; Azzi A; Chapman MS
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10405-10. PubMed ID: 12136130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.
    Girod A; Ried M; Wobus C; Lahm H; Leike K; Kleinschmidt J; Deléage G; Hallek M
    Nat Med; 1999 Sep; 5(9):1052-6. PubMed ID: 10470084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.
    Rabinowitz JE; Rolling F; Li C; Conrath H; Xiao W; Xiao X; Samulski RJ
    J Virol; 2002 Jan; 76(2):791-801. PubMed ID: 11752169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering adeno-associated virus for one-step purification via immobilized metal affinity chromatography.
    Koerber JT; Jang JH; Yu JH; Kane RS; Schaffer DV
    Hum Gene Ther; 2007 Apr; 18(4):367-78. PubMed ID: 17437357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.
    Rutledge EA; Halbert CL; Russell DW
    J Virol; 1998 Jan; 72(1):309-19. PubMed ID: 9420229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets.
    Wang L; Figueredo J; Calcedo R; Lin J; Wilson JM
    Hum Gene Ther; 2007 Mar; 18(3):185-94. PubMed ID: 17324107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AAV8 capsid variable regions at the two-fold symmetry axis contribute to high liver transduction by mediating nuclear entry and capsid uncoating.
    Tenney RM; Bell CL; Wilson JM
    Virology; 2014 Apr; 454-455():227-36. PubMed ID: 24725949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AAV-mediated liver-directed gene therapy.
    Sands MS
    Methods Mol Biol; 2011; 807():141-57. PubMed ID: 22034029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of adeno-associated virus capsid stability and dynamics.
    Rayaprolu V; Kruse S; Kant R; Venkatakrishnan B; Movahed N; Brooke D; Lins B; Bennett A; Potter T; McKenna R; Agbandje-McKenna M; Bothner B
    J Virol; 2013 Dec; 87(24):13150-60. PubMed ID: 24067976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin- binding ability and introduced novel tropism.
    Shi X; Fang G; Shi W; Bartlett JS
    Hum Gene Ther; 2006 Mar; 17(3):353-61. PubMed ID: 16544984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo.
    Gabriel N; Hareendran S; Sen D; Gadkari RA; Sudha G; Selot R; Hussain M; Dhaksnamoorthy R; Samuel R; Srinivasan N; Srivastava A; Jayandharan GR
    Hum Gene Ther Methods; 2013 Apr; 24(2):80-93. PubMed ID: 23379478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.